Biological Assessment of Triazine Dendrimer: Toxicological Profiles, Solution Behavior, Biodistribution, Drug Release and Efficacy in a PEGylated, Paclitaxel Construct-Reference-Cited by-同舟云学术

Biological Assessment of Triazine Dendrimer: Toxicological Profiles, Solution Behavior, Biodistribution, Drug Release and Efficacy in a PEGylated, Paclitaxel Construct

Published:2010-06-29 Issue:4 Volume:7 Page:993-1006
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Lo Su-Tang¹,Stern Stephan¹,Clogston Jeffrey D.¹,Zheng Jiwen¹,Adiseshaiah Pavan P.¹,Dobrovolskaia Marina¹,Lim Jongdoo¹,Patri Anil K.¹,Sun Xiankai¹,Simanek Eric E.¹

Affiliation:

1. Department of Radiology, University of Texas Southwestern Medical Center, Dallas, Texas 75390, Department of Chemistry, Texas A&M University, College Station, Texas 77843-3255, and Nanotechnology Characterization Laboratory, Advanced Technology Program, SAIC-Frederick Inc., NCI-Frederick, Frederick, Maryland 21702

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/mp100104x

Reference45 articles.

1. Paclitaxel chemotherapy: from empiricism to a mechanism-based formulation strategy

2. Docetaxel and Paclitaxel in the Treatment of Breast Cancer: A Review of Clinical Experience

3. Paclitaxel and its formulations

4. The dawning era of polymer therapeutics

5. The heart of the matter

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Building synergistic nanoplatforms via dendrimer-small organic molecule handshakes: Heterocycle ligation as a promising strategy;Materials Today Chemistry;2024-06

2. Biodistribution and toxicity assessment of methoxyphenyl phosphonium carbosilane dendrimers in 2D and 3D cell cultures of human cancer cells and zebrafish embryos;Scientific Reports;2023-09-19

3. A Theranostic Small-Molecule Prodrug Conjugate for Neuroendocrine Prostate Cancer;Pharmaceutics;2023-02-01

4. Dendrimer–drug conjugates;Polymer-Drug Conjugates;2023

5. Recent Reviews on Dendrimers as an Immunotherapy-based Nanosystem for the Effective Treatment of Cancer;Drug Delivery Letters;2022-12